[HTML][HTML] Acute kidney injury following cardiac surgery: current understanding and future directions

JB O'Neal, AD Shaw, FT Billings - Critical care, 2016 - Springer
Acute kidney injury (AKI) complicates recovery from cardiac surgery in up to 30% of patients,
injures and impairs the function of the brain, lungs, and gut, and places patients at a 5-fold …

Extracellular vesicles in renal disease

D Karpman, A Ståhl, I Arvidsson - Nature Reviews Nephrology, 2017 - nature.com
Extracellular vesicles, such as exosomes and microvesicles, are host cell-derived packages
of information that allow cell–cell communication and enable cells to rid themselves of …

Mesenchymal stem cell‐based therapy for kidney disease: a review of clinical evidence

AJ Peired, A Sisti, P Romagnani - Stem cells international, 2016 - Wiley Online Library
Mesenchymal stem cells form a population of self‐renewing, multipotent cells that can be
isolated from several tissues. Multiple preclinical studies have demonstrated that the …

Extracellular vesicles in renal diseases: more than novel biomarkers?

U Erdbrügger, TH Le - Journal of the American Society of …, 2016 - journals.lww.com
Extracellular vesicles from the urine and circulation have gained significant interest as
potential diagnostic biomarkers in renal diseases. Urinary extracellular vesicles contain …

[HTML][HTML] The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury

A Ranghino, S Bruno, B Bussolati, A Moggio… - Stem cell research & …, 2017 - Springer
Abstract Background Mesenchymal stromal cells (MSCs) and renal stem/progenitors
improve the recovery of acute kidney injury (AKI) mainly through the release of paracrine …

[HTML][HTML] Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies

N D'souza, F Rossignoli, G Golinelli, G Grisendi… - BMC medicine, 2015 - Springer
Regenerative medicine relying on cell and gene therapies is one of the most promising
approaches to repair tissues. Multipotent mesenchymal stem/stromal cells (MSC), a …

Acute kidney injury as a condition of renal senescence

L Andrade, CE Rodrigues, SA Gomes… - Cell …, 2018 - journals.sagepub.com
Acute kidney injury (AKI), characterized by a sharp drop in glomerular filtration, continues to
be a significant health burden because it is associated with high initial mortality, morbidity …

[HTML][HTML] Bone marrow mesenchymal stem cell-derived exosomal miR-34c-5p ameliorates RIF by inhibiting the core fucosylation of multiple proteins

X Hu, N Shen, A Liu, W Wang, L Zhang, Z Sui, Q Tang… - Molecular Therapy, 2022 - cell.com
Renal interstitial fibrosis (RIF) is an incurable pathological lesion in chronic kidney diseases.
Pericyte activation is the major pathological characteristic of RIF. Fibroblast and …

[HTML][HTML] CSA-AKI: incidence, epidemiology, clinical outcomes, and economic impact

A Schurle, JL Koyner - Journal of Clinical Medicine, 2021 - mdpi.com
Cardiac surgery-associated acute kidney injury (CSA-AKI) is a common complication
following cardiac surgery and reflects a complex biological combination of patient pathology …

[HTML][HTML] Mitochondrial transplantation ameliorates ischemia/reperfusion-induced kidney injury in rat

H Jabbari, AM Roushandeh, MK Rostami… - … et Biophysica Acta (BBA …, 2020 - Elsevier
No real therapeutic modality is currently available for Acute kidney injury (AKI) and if any,
they are mainly supportive in nature. Therefore, developing a new therapeutic strategy is …